288 related articles for article (PubMed ID: 18353497)
1. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
Moor CT; Roberts SA; Simmons G; Briggs S; Morris AJ; Smith J; Heffernan H
J Hosp Infect; 2008 Apr; 68(4):355-62. PubMed ID: 18353497
[TBL] [Abstract][Full Text] [Related]
2. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
[TBL] [Abstract][Full Text] [Related]
3. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
4. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.
Briongos-Figuero LS; Gómez-Traveso T; Bachiller-Luque P; Domínguez-Gil González M; Gómez-Nieto A; Palacios-Martín T; González-Sagrado M; Dueñas-Laita A; Pérez-Castrillón JL
Int J Clin Pract; 2012 Sep; 66(9):891-6. PubMed ID: 22897466
[TBL] [Abstract][Full Text] [Related]
7. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
Giraud-Morin C; Fosse T
Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
Arpin C; Dubois V; Maugein J; Jullin J; Dutilh B; Brochet JP; Larribet G; Fischer I; Quentin C
J Clin Microbiol; 2005 Oct; 43(10):5048-54. PubMed ID: 16207960
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
[TBL] [Abstract][Full Text] [Related]
12. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
[TBL] [Abstract][Full Text] [Related]
14. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel.
Laupland KB; Church DL; Vidakovich J; Mucenski M; Pitout JD
J Infect; 2008 Dec; 57(6):441-8. PubMed ID: 18990451
[TBL] [Abstract][Full Text] [Related]
15. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
16. Extended-spectrum beta-lactamase-producing Enterobacteriaceae at Middlemore Hospital.
Briggs S; Ussher J; Taylor S
N Z Med J; 2005 Jul; 118(1218):U1563. PubMed ID: 16027752
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.
Skippen I; Shemko M; Turton J; Kaufmann ME; Palmer C; Shetty N
J Hosp Infect; 2006 Oct; 64(2):115-23. PubMed ID: 16859810
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of extended-spectrum beta-lactamases.
Rodríguez-Baño J; Pascual A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
[TBL] [Abstract][Full Text] [Related]
19. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
20. Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients.
Peña C; Gudiol C; Tubau F; Saballs M; Pujol M; Dominguez MA; Calatayud L; Ariza J; Gudiol F
Clin Microbiol Infect; 2006 Mar; 12(3):279-84. PubMed ID: 16451416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
